Reference number : 033-2024-2025-Q1-819773, amendment number : , agreement type : O, recipient legal name : Providence Therapeutics Holdings Inc., recipient country : CA, recipient province : AB, recipient city : Calgary, recipient postal code : T2J3J1, program name english : SIF Stream2- Growth, program name french : FIS Volet 2- Croissance, program purpose english : -Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector., program purpose french : -favoriser les activités de R-D qui accéléreront le transfert de la technologie et la commercialisation de produits, de processus et de services novateurs ;-faciliter la croissance et l'expansion des entreprises au Canada ;-attirer et conserver des investissements de grande envergure au Canada ; et-faire progresser la recherche industrielle, le développement et la démonstration de technologies grâce à la collaboration entre les universitaires, les organisations à but non lucratif et le secteur privé., agreement title english : Enhancing Canadian Innovation in Biomanufacturing and R&D in mRNA Medicines, agreement title french : Renforcer l'innovation canadienne dans la biomanufacturation et la R&D des médicaments à ARNm, agreement number : 819773, agreement value : 49900000.0, agreement start date : 2024-05-23, agreement end date : 2044-01-01, description english : Enhancing Canadian Innovation in Biomanufacturing and R&D in mRNA Medicines, description french : Enhancing Canadian Innovation in Biomanufacturing and R&D in mRNA Medicines, expected results english : nan, expected results french : nan, additional information english : Agreement Type is PRC, 2022/23 to 2026/27,, additional information french : Agreement Type is PRC, 2022/23 à 2026/27,, owner organization : ic, owner organization title : Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada